PROTRACT Trademark

Trademark Overview

On Wednesday, September 7, 2016, a trademark application was filed for PROTRACT with the United States Patent and Trademark Office. The USPTO has given the PROTRACT trademark a serial number of 87162988. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 2, 2024. This trademark is owned by MERCK KGAA. The PROTRACT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research in the field of multiple sclerosis; clinical research in the field of multiple sclerosis
protract

General Information

Serial Number87162988
Word MarkPROTRACT
Filing DateWednesday, September 7, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 2, 2024
Registration Number5387652
Registration DateTuesday, January 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements

Goods and ServicesMedical research in the field of multiple sclerosis; clinical research in the field of multiple sclerosis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 2, 2024
Primary Code042
First Use Anywhere DateSaturday, April 30, 2016
First Use In Commerce DateSaturday, April 30, 2016

Trademark Owner History

Party NameMERCK KGAA
Party Type30 - Original Registrant
Legal Entity Type31 - NOT AVAILABLE
Address64293 Darmstadt
DE
Party NameMERCK KGAA
Party Type20 - Owner at Publication
Legal Entity Type31 - NOT AVAILABLE
Address64293 Darmstadt
DE
Party NameMERCK KGAA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
Address64293 Darmstadt
DE

Trademark Events

Event DateEvent Description
Saturday, September 10, 2016NEW APPLICATION ENTERED
Monday, September 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 4, 2016ASSIGNED TO EXAMINER
Monday, November 14, 2016NON-FINAL ACTION WRITTEN
Monday, December 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 14, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 14, 2016NON-FINAL ACTION E-MAILED
Monday, December 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 28, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, September 15, 2017TEAS STATEMENT OF USE RECEIVED
Friday, September 15, 2017USE AMENDMENT FILED
Thursday, September 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 17, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 18, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 20, 2017WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Tuesday, December 19, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 2, 2024CANCELLED SEC. 8 (6-YR)
Monday, December 18, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 21, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 21, 2017SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 21, 2017NON-FINAL ACTION E-MAILED
Tuesday, November 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2017ASSIGNED TO LIE
Wednesday, December 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

protract sclerosis multiple field research clinical medical